title: Effect of FK 506 on human hepatic cytochromes P-450: interaction with CyA.
authors.affiliation: INSERM U128, Centre Paul Lamarque, Montpellier, France.
authors.forename: L
authors.initials: L
authors.lastname: Pichard
authors.forename: I
authors.initials: I
authors.lastname: Fabre
authors.forename: J
authors.initials: J
authors.lastname: Domergue
authors.forename: H
authors.initials: H
authors.lastname: Joyeux
authors.forename: P
authors.initials: P
authors.lastname: Maurel
mesh_terms: D002478:Cells, Cultured; D016572:Cyclosporine / Q000378:metabolism* / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000378:metabolism*; D004790:Enzyme Induction; D006801:Humans; D007527:Isoenzymes / Q000096:biosynthesis / Q000378:metabolism*; D008099:Liver / Q000201:enzymology*; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D010634:Phenobarbital / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D016559:Tacrolimus / Q000494:pharmacology*
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D007527:Isoenzymes; D016572:Cyclosporine; D003577:Cytochrome P-450 Enzyme System; D012293:Rifampin; D016559:Tacrolimus; D010634:Phenobarbital